Yes, Long COVID Is Recognized as a Medical Diagnosis
Long COVID (post-COVID-19 condition) is formally recognized as a medical diagnosis by major health organizations including the WHO and CDC, and has been assigned the ICD-10-CM diagnostic code U09.9 since October 2021 1, 2, 3.
Official Definitions and Diagnostic Criteria
The WHO defines post-COVID-19 condition as persistent symptoms and/or signs developing during or after acute COVID-19, lasting at least 2 months and persisting beyond 12 weeks from the acute disease, that cannot be explained by an alternative diagnosis 1. The CDC provides a similar definition 1.
More recently, the National Academies of Sciences, Engineering, and Medicine defines Long COVID as "an infection-associated chronic condition that occurs after SARS-CoV-2 infection and is present for at least 3 months as a continuous, relapsing and remitting, or progressive disease state that affects one or more organ systems" 4.
Diagnostic Classification System
Long COVID can be classified based on certainty of original COVID-19 infection 1:
- Definite: Typical symptoms with positive laboratory results
- Probable: Typical symptoms with negative laboratory results but suggestive epidemiology
- Possible: Typical symptoms with negative laboratory results and negative epidemiology
Importantly, a positive COVID-19 test during acute infection is NOT required to diagnose Long COVID 4.
Timeline Distinctions
The guidelines establish clear temporal definitions 1:
- Acute COVID-19: Symptoms up to 4 weeks
- Post-acute COVID: Symptoms persisting 4-12 weeks after confirmed diagnosis
- Long COVID: Symptoms persisting or relapsing/remitting for more than 12 weeks since acute COVID-19 diagnosis
Recognition in Clinical Practice
Long COVID is recognized as a potential disability under the Americans with Disabilities Act 4. The condition has been incorporated into the ICD-10 classification system since September 2020, with the specific code U09.9 implemented for clinical documentation in October 2021 2, 3.
Clinical data from U.S. primary care settings shows over 10,000 patients received the U09.9 diagnosis code between October 2021 and June 2023, demonstrating active clinical use of this diagnostic entity 3.
Clinical Characteristics Supporting Diagnosis
The most commonly observed symptoms include 1:
- Fatigue (31-58%)
- Dyspnea (24-40%)
- Cognitive impairment/brain fog (12-35%)
- Sleep disturbances (11-44%)
- Musculoskeletal pain (9-19%)
- Cough (7-29%)
- Anosmia/dysgeusia (10-22%)
- Chest pain (6-17%)
Long COVID is a diagnosis of exclusion 1. Before making this diagnosis, clinicians must rule out:
- Previously overlooked conditions (e.g., malignancy)
- Complications of acute COVID-19 (e.g., thromboembolic events, myocarditis, encephalitis)
- Iatrogenic causes
- Post-intensive care syndrome (for those who required critical care)
Global Prevalence and Impact
The current global prevalence of Long COVID is estimated at 6%, though this varies by population 4. A systematic review found that 57% of patients with symptoms persisting beyond 12 weeks reported decreased quality of life 1.
Important Caveats
While Long COVID is formally recognized, several challenges remain:
- No consensus on single terminology: Various terms are used (long COVID, post-COVID-19 condition, post-acute sequelae of SARS-CoV-2 infection, chronic COVID syndrome) 1, 2
- No definitive diagnostic test: Currently, there is no single laboratory finding that definitively confirms or rules out Long COVID 4
- Evolving definitions: The consensus definition is likely to change as knowledge increases 2
- Potential diagnosis gap: Clinical data suggests underdiagnosis, particularly among patients with rural residence or high socioeconomic deprivation 3
The recognition of Long COVID as a formal medical diagnosis provides a foundation for clinical care, research, disability accommodations, and healthcare resource allocation, despite ongoing uncertainties about optimal diagnostic and treatment approaches.